Health | The TimesThe latest news and comment from thetimes.co.uken-ukCopyright 2015 Times Newspapers Ltd.support@thetimes.co.ukhttp://www.thetimes.co.uk
Sun, 02 Aug 2015 18:46:05 GMTNewspapersThe Times14434http://www.thetimes.co.uk/tto/feedindex/
http://www.thetimes.co.uk/tto/public/img/thetimes144.gifAstra defies generics to exceed forecastsFri, 31 Jul 2015 00:01:00 GMT2015-07-30T11:11:13ZAstraZeneca has reported a better-than-expected first half, even as competition from generic drug rivals caused a drop in earnings.
Its...Successful knee operation has Smith & Nephew walking tallFri, 31 Jul 2015 00:01:00 GMT2015-07-30T11:13:51ZThe perennial takeover target Smith & Nephew reported a strong first half with profits jumping as more people worldwide underwent...Addicts enable Indivior to lift its forecastThu, 30 Jul 2015 00:01:00 GMT2015-07-29T10:20:16ZA pharmaceutical company spun off from Reckitt Benckiser that makes treatments for drug addicts has raised full-year profit guidance by 30...New bribery claims cast pall on GSK resultsThu, 30 Jul 2015 00:01:00 GMT2015-07-30T07:41:01ZBritain’s biggest pharmaceutical company is facing fresh allegations of bribery and corruption that will cast a pall over a better-than-expected...Hikma Pharmaceuticals gets a $1bn pick-me-up with US dealWed, 29 Jul 2015 00:01:00 GMT2015-07-28T11:13:46ZA Jordan-based pharmaceutical company has snapped up a rival American group in
a $1.18 billion deal as the wave of consolidation...Astra clears another drug off the shelfTue, 28 Jul 2015 00:01:00 GMT2015-07-27T07:36:34ZAstraZeneca has sold one of its rare disease medicines to Sanofi as it refines its portfolio and raises cash.
The...Teva homes in on Allergan genericsMon, 27 Jul 2015 00:01:00 GMT2015-07-26T07:48:30ZThe global surge in mergers and acquisitions among pharmaceuticals groups will continue this week with an agreed takeover of the...Shire swallows bitter pill after double failure in drug trialsFri, 24 Jul 2015 00:01:00 GMT2015-07-23T08:16:11ZDisappointing clinical trial results for two of Shire’s rare-disease drugs have forced the pharmaceuticals company to take a financial writedown...Malaria vaccine is first in fight against fatal parasiteFri, 24 Jul 2015 00:01:00 GMT2015-07-23T10:59:19ZThe first malaria vaccine is expected to be approved by regulators today in a significant advance in the battle against...Inquiry into ‘drug cash for NHS officials’Fri, 24 Jul 2015 00:01:00 GMT2015-07-24T12:19:05ZClaims that NHS officials were paid thousands of pounds and entertained in
hotels around the world by drug companies lobbying...It’s an ill wind that blows nobody any good, even when it’s a sneezeWed, 22 Jul 2015 00:01:00 GMT2015-07-21T06:55:24ZA motorcycle helmet full of mucus must be one of the most unlikely
inspirations for a business, but for Max Wiseberg,...Former high-flyer handed ten-year accountancy banWed, 22 Jul 2015 00:01:00 GMT2015-07-21T08:56:22ZThe former finance director of one of the biggest providers of temporary workers to the NHS has been barred by...Biotech firm raises record £200m to help cancer fightFri, 17 Jul 2015 00:01:00 GMT2015-07-17T12:38:54ZAn Oxford university spin-out company with a new approach to tackling cancer
has raised £205 million in the biggest private...Drugstore cowboy steps out with British beautyFri, 10 Jul 2015 00:01:00 GMT2015-07-10T10:16:11ZWalgreens Boots Alliance, the big American drug store company that owns the
Boots chain in the UK, has confirmed Stefano...US health insurers in $37bn merger as Obamacare boomsSat, 04 Jul 2015 00:01:00 GMT2015-07-03T11:34:10ZTwo of the biggest US health insurers are to merge, with Aetna paying $37
billion to buy its smaller rival...Aetna in $37bn swoop for rival health insurer HumanaFri, 03 Jul 2015 11:30:30 GMT2015-07-03T10:21:39ZIn a bumper week for mergers and acquisitions in the insurance sector,
America’s Aetna group has agreed to buy rival,...AstraZeneca loses second key executiveThu, 25 Jun 2015 00:01:00 GMT2015-06-24T07:53:48ZA top executive at AstraZeneca has quit to become the chief executive of
Vectura, a developer of respiratory drugs, in the...Underlying profits boost for Priory GroupThu, 25 Jun 2015 00:01:00 GMT2015-07-24T11:21:00ZThe owner of The Priory, famed as the stars’ favourite psychiatric clinic, has
posted an improvement in underlying profits as...South Africans give Spire’s hospitals shot in the armTue, 23 Jun 2015 00:01:00 GMT2015-06-23T12:07:33ZA South African hospital investor has bought a 29 per cent stake in Spire
Healthcare in a bet that an NHS...PureTech’s healthy vote of confidence in London marketSat, 20 Jun 2015 00:01:00 GMT2015-06-19T10:38:27ZAn American life sciences company promoting the development of “disruptive”
healthcare treatments for obesity, schizophrenia and autism has floated in...AstraZeneca loses its top scientist at a critical timeThu, 11 Jun 2015 00:01:00 GMT2015-06-11T12:17:12ZAstraZeneca’s most senior scientist is leaving the drugs company in the middle
of an effort to revitalise productivity in the...Jailed Glaxo investigator is freed early by Chinese courtWed, 10 Jun 2015 00:01:00 GMT2015-06-10T11:41:24ZA British private investigator who was jailed in China after being hired by
GlaxoSmithKline to look into a sex and bribery...Bitter pill for Witty as he loses top slot with staffWed, 10 Jun 2015 00:01:00 GMT2015-06-10T08:28:44ZYou might think GlaxoSmithKline reinventing itself from blockbuster drugs
factory to the affordable medicine cabinet of the developing world would...Acquisitive Shire offers new home to Swiss expert in orphan diseasesMon, 08 Jun 2015 00:01:00 GMT2015-06-08T07:53:24ZA British specialist in psychiatric medicines for hyperactive teenagers and in treatments for so-called orphan diseases is considering bidding for a...Spire to shut St Saviour’s hospitalWed, 03 Jun 2015 00:01:00 GMT2015-06-02T11:52:58ZA hospital set up by Anglican nuns in 1892 is to be shut down by Spire Healthcare because it would be...Too much synergy puts deal in troubleSat, 30 May 2015 00:01:00 GMT2015-05-29T08:15:48ZConcerns about competition in the American market for surgical sterilisation could scupper a $1.9 billion tie-up between Synergy Health and...Teva to pay $1.2bn over monopoly protectionFri, 29 May 2015 00:01:00 GMT2015-05-28T10:59:34ZTeva Pharmaceuticals, the Israeli generic drugmaker, which is engaged in a $40
billion hostile takeover battle, has agreed to pay...Synergy’s takeover plan on a knife-edgeThu, 28 May 2015 00:01:00 GMT2015-05-27T07:08:17ZFears are growing that a $1.9 billion tie-up between Synergy Health group and Steris Corporation could be blocked by American...PureTech looks to London for healthy financeWed, 27 May 2015 00:01:00 GMT2015-05-27T09:29:48ZA Boston-based healthcare business incubator has turned its back on Silicon Valley, Wall Street and arguably conventional wisdom to cross the...Marijuana drugmaker GW Pharmaceuticals boss swaps Britain for CaliforniaWed, 20 May 2015 00:01:00 GMT2015-05-19T08:14:50ZThe boss of GW Pharmaceuticals, the marijuana-based drugs company, is moving from Britain to southern California as the business increasingly...Astra chooses Sweden over Britain for $285m facilityTue, 19 May 2015 00:01:00 GMT2015-05-18T09:48:58ZAstraZeneca has shunned Britain by choosing Sweden as the location to break
ground on a $285 million drugs factory that...Circassia Pharmaceuticals on the huntSat, 16 May 2015 00:01:00 GMT2015-05-15T09:25:14ZAn Oxford-based biotechnology company is preparing to launch a cat fur allergy
vaccine in the United States after raising cash...Shareholders revolt over pay deal at Reckitt spin-offFri, 15 May 2015 00:01:00 GMT2015-05-14T10:30:14ZMore than a quarter of shareholders have rebelled over a potential $8 million pay package for the boss of Indivior,...Wellcome Trust finds new haven for its cash with £200m Premier Marinas dealWed, 13 May 2015 00:01:00 GMT2015-05-13T12:20:11ZOne of the world’s biggest funders of medical research has gone into the British marinas business.
Wellcome Trust has bought...Fitbit takes run at US flotationFri, 08 May 2015 00:01:00 GMT2015-05-08T09:42:56ZFitness is big business and Fitbit, which is the latest to cash-in on the
boom, has got off to a...Sir Andrew Witty has billions at stake – that’s lives, not just cashThu, 07 May 2015 00:01:00 GMT2015-05-06T09:26:00ZIf Sir Andrew Witty is feeling the pressure, he isn’t showing it. The chief
executive of GlaxoSmithKline was the epitome...GlaxoSmithKline chief Sir Andrew Witty bets all on radical shake-upThu, 07 May 2015 00:01:00 GMT2015-05-07T09:03:08ZSir Andrew Witty set out plans yesterday to reshape GlaxoSmithKline in the
last throw of the dice for the chief...Watchdog warns Smith & Nephew on rule ‘violations’Wed, 06 May 2015 00:01:00 GMT2015-05-05T11:01:26ZAmerica’s healthcare watchdog has warned Smith & Nephew over
regulatory failures involving the sale of a gynaecology device.
In a...Editor gets sack in row over publisherTue, 05 May 2015 00:01:00 GMT2015-05-07T05:00:51ZThe editor of the Medical Journal of Australia has been dismissed after
he objected to outsourcing the 101-year-old journal’s production...Pets, vets and very large billsMon, 04 May 2015 00:01:00 GMT2015-05-03T08:55:50ZFlying lessons for a cockatiel and treatment for a tortoise with a bad stomach
were among pet owners’ claims that...Glaxo may cancel £4bn cash return to investorsSat, 02 May 2015 00:01:00 GMT2015-05-01T08:34:17ZGlaxoSmithKline may ditch a pledge to return £4 billion to investors in a
strategic shake-up that could involve deep cost...Shire profits from new use for drugFri, 01 May 2015 00:01:00 GMT2015-04-30T10:38:36ZPrescriptions to treat binge eating disorder helped Shire to deliver a surge
in sales and profits as the drugs company’s...Check out the Times Business podcastThu, 30 Apr 2015 22:08:18 GMT2015-05-01T08:34:39ZIn the Times Business podcast we take a look at the biggest stories coming up
in election week.
Joining our...GW Pharmaceuticals puts more cash in the pot with fundraisingWed, 29 Apr 2015 00:01:00 GMT2015-04-28T10:36:56ZIt’s a costly business cultivating marijuana, according to GW Pharmaceuticals, the cannabis-based medicines specialist that is tapping American investors for...Pfizer chief plays down second try at AstraZeneca takeoverWed, 29 Apr 2015 00:01:00 GMT2015-04-28T10:34:05ZPfizer has poured cold water on the prospect of a fresh bid for one of
Britain’s leading drugs companies, despite...Shingles vaccine could prove a £1bn-a-year blockbuster for GSKWed, 29 Apr 2015 00:01:00 GMT2015-04-28T10:56:01ZHealthcare analysts believe that GlaxoSmithKline has a potential £1 billion-a-year blockbuster drug on its hands with a vaccine to prevent...GlaxoSmithKline discovers antidote for shinglesTue, 28 Apr 2015 13:22:25 GMT2015-04-28T10:56:08ZHealthcare analysts believe that GlaxoSmithKline has a potential £1
billion-a-year blockbuster drug on its hands in the shape of a...Hostile bid has just become acrimoniousTue, 28 Apr 2015 00:01:00 GMT2015-04-27T09:05:34ZThe world’s biggest generic drugs company has been branded as “dysfunctional”,
with rapid management turnover and a flip-flopping strategy, in...AstraZeneca’s drug sale ‘a short-term boost’Sat, 25 Apr 2015 00:01:00 GMT2015-04-24T09:11:28ZA cancer drug tipped as a future AstraZeneca blockbuster is to be co-developed
by an American biotechnology company under a partnership...Deal for Surrey specialist gives Clinigen a growth spurtSat, 25 Apr 2015 00:01:00 GMT2015-04-27T02:08:34ZClinigen, a drugs company based in Burton-on-Trent that floated on the stock
market three years ago, is to double in...